Built for women's urinary tract and digestive support, this formula leads with **cranberry** at 500mg — right at the studied minimum where Cochrane reviews back it for preventing recurrent UTIs in women by blocking bacteria from sticking to the bladder wall. On the probiotic side you're getting 3.5 billion CFU from two named strains, **Lactobacillus plantarum LP01** and **L. paracasei LPC09** — and naming strains this precisely matters, because probiotic benefits are tied to the specific strain, not just the species.

Worth knowing where that probiotic actually fits: LP01 and LPC09 are studied mainly for gut and digestive balance, not vaginal or urogenital flora. So if you came looking for the classic women's-flora strains studied for vaginal health (like L. rhamnosus GR-1 or L. reuteri RC-14), these aren't those — at 3.5 billion CFU they sit within the effective range for general gut support, toward the lower end.

The clearest gap is **D-Mannose** at 250mg — about a quarter of the 1,000mg minimum used in trials. And even at full doses, the largest recent studies, including a 598-person 2024 RCT, found no benefit over placebo for preventing UTIs. So lean on the cranberry as the real urinary-tract value here, where you're getting a full studied dose, and treat the D-mannose as a minor extra.